PharmAthene (PIP +2.6%) reports that it received $90M from SIGA Technologies related to the settlement of their litigation over smallpox antiviral Arestvyr. It has now received $115M plus $6.6M in interest. SIGA has until the end of November to pay the remaining $93.7M plus interest.
Previously: Delaware Supreme Court upholds $195M judgement to PharmAthene; SIGA files reorganization plan (Dec. 23, 2015)
Subscribe for full text news in your inbox